J&J | Actif À Court Terme



Current Assets Changement Date
AbbVie USD 25.58B 2.2B 2024-12
Abbott USD 23.15B 503M 2025-03
Amgen USD 26.93B 2.1B 2025-03
AstraZeneca USD 26.14B 312M 2025-03
Baxter International USD 8.85B 11M 2024-12
Bayer EUR 34.83B 388M 2025-03
Becton, Dickinson and Co. USD 8.67B 7M 2025-03
Biogen USD 7.63B 169.2M 2025-03
Boston Scientific USD 7.34B 415M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
CONMED USD 639M 1.01M 2025-03
Cooper Companies USD 1.99B 35.5M 2025-01
Dexcom USD 4.55B 252.4M 2025-03
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Eli Lilly USD 41.26B 8.52B 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
GlaxoSmithKline GBP 18.08B 1.09B 2025-03
Globus Medical USD 1.71B 467.15M 2025-03
Hologic USD 3.21B 284.9M 2025-03
Indivior 883M 44M 2025-03
Insulet USD 2.33B 437.1M 2025-03
Integra LifeSciences USD 1.11B 25.57M 2025-03
Intuitive Surgical USD 11.88B 331.3M 2025-03
J&J USD 71.55B 15.66B 2025-03
Medtronic USD 22.51B 75M 2025-01
Merck USD 35.5B 3.28B 2025-03
Merit Medical Systems USD 958.64M 34.86M 2025-03
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 45.86B 4.5B 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 44.02B 1.43B 2025-03
Stryker USD 13.02B 1.83B 2025-03
Tandem Diabetes Care USD 663.44M 61.06M 2025-03
Teva Pharmaceutical Industries USD 11.53B 1.02B 2025-03
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12
Zoetis USD 5.88B 109M 2025-03



J&J Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.